At the Nagourney Cancer Institute, we analyze your living cancer cells to find out the drugs, combinations, and sequences that are most effective for you.
This reduces the guesswork in selecting your cancer treatment by measuring how your cancer cells will respond to drugs BEFORE you receive treatment. This helps select the most effective and least toxic drug regimen for your cancer.
We are an accomplished cancer research and testing facility with a fully accredited federal and state-licensed laboratory.
For over 20 years, we've offered personalized cancer testing that helps select the most effective and least toxic drug regimen for your cancer.
We also work with pharmaceutical and biotechnology firms to streamline their research and development process for bringing new compounds to market.
Dr. Robert Nagourney is an internationally recognized pioneer in cancer research and personalized cancer treatment.
With more than 20 years of experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts, book chapters, and abstracts including publications in the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the National Cancer Institute.
Over the past 20+ years, Dr. Nagourney and his team at the Nagourney Cancer Institute have developed a laboratory technique, functional profiling, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.
By using this approach, the Nagourney team can determine the best drugs for each patient before they receive them. This reduces the guesswork in selecting the right drug treatment for you and is why our analysis is more powerful than genomic testing offered by most centers.